Predicting recurrence in axillary-node negative breast cancer patients

Area of Science:

• Oncology
• Clinical Medicine
• Cancer Research

Background:

• Accurate risk stratification is crucial for optimizing treatment in axillary node-negative breast cancer patients.
• Validated prognostic factors can help identify patients who may benefit from specific therapeutic approaches.

Purpose of the Study:

• To identify distinct risk groups within axillary node-negative breast cancer patients.
• To utilize established clinical and pathological factors for predicting recurrence risk.
• To guide treatment decisions by stratifying patients into low, intermediate, and high-risk categories.

Main Methods:

• Retrospective analysis of 407 axillary node-negative breast cancer patients treated with surgery alone (1976-1987).
• Updated 10-year follow-up to determine recurrence rates (RR).
• Statistical analysis including Cox Model to identify significant predictors: tumor size, histologic differentiation, and age.

Main Results:

• Overall 10-year recurrence rate was 19%.
• Key predictors of recurrence, in order of significance, were tumor size, histologic differentiation (poorly differentiated/anaplastic vs. well/moderately differentiated), and age.
• Identified low-risk groups (e.g., tumors ≤1 cm, well-differentiated) with 0% RR, high-risk groups (e.g., tumors >2 cm) with 32% RR, and intermediate-risk groups.

Conclusions:

• Tumor size, histologic differentiation, and patient age are significant predictors of recurrence in node-negative breast cancer.
• Subgroup analysis allows for precise identification of patients at low risk, potentially sparing them from systemic adjuvant therapy.
• High-risk patients warrant adjuvant therapy, while intermediate-risk patients may benefit from clinical trial enrollment.